Two types of booster shots studied spurred higher levels of virus-halting antibodies against the variant strain P.1 that ravaged Brazil as well as B.1.351, common in South Africa, Moderna said in a statement. One of the boosters is an additional low-dose shot of its existing vaccine, while the other type is customized against the South Africa strain.
Scientists and drugmakers are moving rapidly to head off the rise of coronavirus variants ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.